tomeko

Aniridia-renal agenesis-psychomotor retardation syndrome

Just diagnosed with Aniridia-renal agenesis-psychomotor retardation syndrome?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Aniridia-renal agenesis-psychomotor retardation syndrome, look for clinical trials, and connect with others living with it — all in one place.

Open the full Aniridia-renal agenesis-psychomotor retardation syndrome hub →

Overview

Aniridia-renal agenesis-psychomotor retardation syndrome is a rare condition. Also known as Sommer-Rathbun-Battles syndrome. Tomeko brings together the specialists, research, clinical trials, treatments and community for Aniridia-renal agenesis-psychomotor retardation syndrome so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:1064 · OMIM 206750 · ICD-10 Q87.8 · GARD 0000690

Find care for Aniridia-renal agenesis-psychomotor retardation syndrome

Authoritative references for Aniridia-renal agenesis-psychomotor retardation syndrome

Common questions

I was just diagnosed with Aniridia-renal agenesis-psychomotor retardation syndrome — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Aniridia-renal agenesis-psychomotor retardation syndrome, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Aniridia-renal agenesis-psychomotor retardation syndrome?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Aniridia-renal agenesis-psychomotor retardation syndrome, filtered to your area.

Are there clinical trials for Aniridia-renal agenesis-psychomotor retardation syndrome?

Tomeko shows live, recruiting studies for Aniridia-renal agenesis-psychomotor retardation syndrome from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com